In the past week, my NL only team caught fire, nosing into 4th place, only 4 points out of first. All of those gains were given back by Oliver Perez, Francisco Cordero and batters going 6 for 41 on Saturday. I’m not worried about Perez/Cordero, but I am worried about my hitting. If I’m going to compete this year, now’s my time to make a move, so I intend to complete “taking stock” this week, and to try to get a deal done within two weeks.
I’m not thrilled with my 1B situation, which I analyzed in a post a few days ago. Moving right along, the rest of my infield situation is ok at best:
Second Base
Js. Valentin, Mets, 5 s2
I auctioned Valentin as a source of cheap power, and understood that he could be a drag on average; with 25 hr potential, getting him for 5 at the auction seemed like a steal. He started off well, then got hurt, and has now returned to the lineup. I missed a chance to get Damien Easley in the FAAB draft the Wednesday after Valentin’s injury. I bid 8; Easley went for 13. Why didn’t I go higher? I was the one who needed him. I was seduced by a fantasy article which claimed that Easley would split time with Ruben Gotay. Really? An established veteran with pop was going to split time with a light hitting rookie? What was I thinking? This nugget kept me from bidding an amount which I “knew” would be enough, instead of bidding low and trying to get Easley on the cheap. So for the first few weeks I had a hole in my lineup, instead of reaping the fruits of Easley’s power surge. Hopefully, lesson learned. In the interim, I faabed K. Fransden (2b SF) for $1, and he’s reverted to his utility role with R Durham back from injury.
In a small sample size, Valentin’s ops of .789 is providing me about $4 worth of production. Valentin has no trade value, and I will keep him in the hopes that he provides the cheap power that I bid on, and that he can keep his average up around .260.
Tony Abreu, 2b (3b) LAD
I faabed Abreu this week for $7. Based upon what I’ve read it seems like the Dodgers prefer W. Betemit coming off the bench and that Abreu will get most of the playing time. Being eligible at 2b is a nice plus, given the uncertainty of Valentin as a fantasy producer.
Abreu’s OPS is about the same as Valentin’s, but with a better avg. and less slg. His high contact rate 89% accounts for a higher average, and his xBA (329) is almost 30 points higher than actual avg. (304). Abreu’s walk rate of 3% does worry me, but this may be a function of pitchers simply refusing to walk him.
If Abreu sticks, it will give my lineup a little flexibility in terms of looking to raise my average or hit for power. If one of these two work out, then my middle infield’s fine, because I’m very strong at shortstop.
R. Furcal, ss LAD
I auctioned Furcal for $29 this year with the knowledge that the first two weeks will be spent on the DL with a sprained ankle. Two weeks is a blip on the season’s radar, and he went a full $13 less than Jimmy Rollins, the other ss I was targeting. Shandler said that he could be primed for a career year, with 20 hr/40 sb and a .310 average all attainable.
Furcal started slowly, as he did last year. No homers and only 7 stolen bases to date is disappointing. He is hitting .293, though his xBA is .254. Furcal’s walk % (10) and contact rate (89%) are right at his career norms. I need the free swingers in the LAD lineup to give Furcal a chance to swipe a few bases, and at this point, will take 10+ hrs for the rest of the year. If my league thinks that I’m going to give Furcal away in a dump deal, they have another thing coming. He should be keepable at $29 for next year, barring injury.
Alex Gonzalez, SS Cin
I auctioned AGone for $5 based in part on Shandler’s note that his poor first half in 2006 was likely due to recovery from elbow surgery, and that a strong 2nd half indicated a possible return to 2003-04 form, where he hit 41 hrs combined. AGone’s only 30, and so far he’s having a “career year”:
| AB | H | AVG | OBP | HR | RBI | SB | R | CS | 2B | 3B | BB | K | |||||||
| 214 | 56 | .262 | .309 | 11 | 26 | 0 | 32 | 1 | 14 | 1 | 11 | 37 | |||||||
With a hit rate of 27% and an xBA of .295, AGone’s been a little unlucky, and he recently missed three games with a sore hammy. As an historically low average hitter, he has raised his contact rate a few points the last two years. I’ll take a .262 average the rest of the way if he can keep up the power.
I’m not sure how much value AGone has in the trade market, but I think his true value is still higher than his perceived value. It’s likely that I will hold onto AGone for the rest of the year.
Third Base - Pedro Feliz (SF) and Kevin Kouzmanoff (SD)
Interestingly, I auctioned both for $12. Feliz, whom I’ve owned
in the past, is a “guaranteed” producer:
| YEAR | TM | GM | AB | HITS | AVG | OBP | 2B | 3B | HR | RBI | R | SB | CS | BB | K |
| 2006 | SF | 160 | 603 | 147 | .244 | .283 | 35 | 5 | 22 | 98 | 75 | 1 | 1 | 33 | 112 |
| 2005 | SF | 156 | 569 | 142 | .250 | .297 | 30 | 4 | 20 | 81 | 69 | 0 | 2 | 38 | 102 |
| 2004 | SF | 144 | 503 | 139 | .276 | .308 | 33 | 3 | 22 | 84 | 72 | 5 | 2 | 23 | 85 |
his avg should be higher than .263, but an unlucky 27% hit rate has hurt his numbers.
There’s something to be said for a player like Feliz. At some point, he will outlive his
usefulness to the Giants, and they will look for a more dynamic offensive player at 3B.
Right now, I think he’ll continue to produce at least through the end of this year.
Kouzmanoff was a speculative play. Shandler noted that he hit .300
with plus power at very level in the minors. He was slotted in to be
the starting 3b at San Diego, who has been very patient with him:
| GM | AB | H | AVG | OBP | HR | RBI | SB | R | CS | 2B | 3B | BB | K | E | A |
| 51 | 162 | 35 | .216 | .284 | 4 | 25 | 0 | 13 | 0 | 10 | 1 | 14 | 43 | 8 | 65 |
Looking at the monthly splits in the “bpi’s“, (base performance
indexes compiled at baseballhq.com) shows a recovery from a
disastrous April:
2007 AB bb% ct% Eye PX xBA==== == === === ==== === ====Apr 71 5 69 0.18 58 .173May 66 11 79 0.57 193 .299
that he’s still in the majors. The perception is that he’s back, and should produce
decent stats the rest of the year. It doesn’t appear that he will hit 20 homers this year,
but he could hit .300 the rest of the way.
If he’s a “buy low” candidate for another team, possibly playing for next year, I wouldn’t be against moving him to fill another need.
Overall, my infield is filled with players who are either underperforming
or are right where they should be, with the exception of Gonzalez, who’s exceeding his established level. As a resultI don’t see too much here that would generate value in a trade, possibly a throwback to “even out” a deal. That said, I do expect fairly solid production from my infield the rest of the way, anchored by a hopefully resurgent Furcal.



0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment